Skip to main content

This job has expired

You will need to login before you can apply for a job.

Associate Director, Regulatory CMC

Employer
Intellia Therapeutics
Location
Cambridge, MA
Start date
Jun 7, 2023

View more

Discipline
Regulatory, Regulatory Affairs, Science/R&D, CMC
Required Education
Masters Degree/MBA
Position Type
Full time
Hotbed
Genetown, Best Places to Work

Job Details

Why Join Intellia?

Our mission is to develop curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.

Beyond our science, we live our four core values: One, Explore, Disrupt, Deliver and feel strongly that you can achieve more at Intellia. We have a single-minded determination to excel and succeed together. We believe in the power of curiosity and pushing boundaries. We welcome challenging thoughts and imagination to develop innovative solutions. And we know that patients are counting on us to make the promise a reality, so we must maintain high standards and get it done.

We wantall ofour people to go beyond what is possible. We aren’t constrained by typical end rails, and we aren’t out to just “treat” people. We’re all in this for something more. We’re driven to cure and motivated for change. Just imagine the possibilities of what we can do together.

How You Will Achieve More With Intellia:

Reporting to the Director, Regulatory CMC, the Associate Director of Regulatory CMC will be responsible for the development and submission of regulatory filings for CRISPR/Cas9- based gene therapy projects, in the US and internationally. The individual will help drive the development of innovative CMC regulatory strategies to support INDs, CTAs, and eventual original marketing applications (BLAs/MAAs), in close collaboration with the CMC team, the internal technical functions, contract manufacturing organizations, and external consultants and collaborators.

This opportunity will offer you the chance to grow your Regulatory Affairs CMC expertise across a range of disciplines such as nucleic acid therapeutics, lipid-nanoparticle drug delivery, and also viral delivery systems and a range of cell therapy products.

  • Provide regulatory CMC strategic leadership to support the development of late-phase gene therapy products for the treatment of severe genetic diseases

  • Support preparation of high-quality clinical trial applications in the US, EU and ROW. Independently manage responses to CMC questions. Work closely with the technical team and regulatory project managers to ensure the achievement of submission deadlines

  • Design and drive negotiations with regulatory agencies globally in preparation for late-phase clinical development and marketing applications; support interactions with regulatory agencies during GMP and pre-approval inspections

  • Work very closely and creatively with technical teams to support the implementation of manufacturing and analytical development strategies

  • Identify and clearly communicate regulatory opportunities and challenges to both the technical team and the clinical regulatory strategy team, to appropriately influence overall strategies and maximize the probability of regulatory success

  • Represent Intellia at external trade associations and conferences.

  • Analyze regulatory guidelines and regulatory trends/expectations in the fast-evolving field of cell and gene therapy

  • Educate and communicate learnings to the rest of the company, to maximize regulatory success

  • Support the development of internal regulatory processes and standards

  • Ensure regulatory compliance with existing guidelines and expectations through timely assessment of change controls and deviations, and timely completion of quality trainings

About You:

Our ideal candidate will have directly contributed to or led a major marketing application for cell and/or gene therapy products. If you describe yourself as creative minded, an excellent communicator and a team player, we encourage you to apply and grow with us! Other desired skills include:

  • Master’s degree in life sciences in biochemistry, chemistry, biology (cell/molecular) or related pharmaceutical fields including biochemical engineering; Candidates holding a higher degree, such as a PhD will be given preference

  • Minimum 6-8 years of relevant biopharmaceutical industry experience, with at least 5 years of experience in CMC-focused Regulatory Affairs for biologics

  • Experience working with cell/gene therapy products, or mRNA-based therapeutics is strongly preferred

  • Late-stage regulatory CMC program/project leadership (Phase III IND/CTA, MAA/BLA) and experience with viral or non-viral vectors are desirable

  • Lead interactions with regulatory health authorities and experience with submitting CTA/IND and BLA/MAA filings, ideally in an area related to gene therapy

  • Strong knowledge of current Good Manufacturing Practices (GMP), drug and biologics development regulations and guidelines including ICH, FDA, and EMA guidelines

Meet your future team:

The Global Regulatory Affairs group is a rapidly growing and valued team within Intellia and is comprised of respected professionals with diverse regulatory expertise in both large pharma and small biotech settings. The Regulatory CMC group is a big part of the GRA function. We are bright, fun, and have a team-first philosophy. Eager to move exciting projects forward, we are motivated by the opportunity to impact patients!

The Global Regulatory Affairs group is ca mix of remote, hybrid, and onsite, and we are open to applicants working remotely for this role. Although in a virtual environment, the group has made it a priority to continue to foster a sense of community! You can expect to join a hardworking, collaborative environment.

Covid-19 Vaccination Policy:All Intellia employees, regardless of work location, are expected to follow all applicable federal, state, and local public health regulations and guidelines, and are strongly encouraged to follow all public health recommendations, including being vaccinated for COVID-19.

EEOC Statement: Intellia believes in a diverse environment, and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Intellia will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.

Company

Many of us pursuing work in the biotechnology industry are inspired by a loved one who is living with a disease or the loss of someone in our community. Rare genetic and oncological and immunological diseases not only affect the people living with often debilitating and life-threatening symptoms, but these disorders also significantly impact their families, friends and caregivers.
 
Our researchers work tirelessly to harness the genome editing technology CRISPR/Cas9 for human therapeutic use. Jennifer Doudna, an Intellia co-founder, and Emmanuelle Charpentier were awarded the 2020 Nobel Prize in Chemistry for their pioneering work in CRISPR. We at Intellia are humbled to have a hand in making what we believe to be medical history. As a leader in this space, we take this responsibility to patients seriously.
 
We are employing a modular genome editing platform to create diverse in vivo and ex vivo pipelines, spanning a range of therapeutic indications. Guided by this full-spectrum approach, we are committed to making CRISPR/Cas9-based medicines a reality for patients suffering from genetic diseases and to creating novel engineered cell therapies for various cancers and autoimmune diseases.

Change life stories with genome editing therapies!

Stock Symbol: NTLA

TwitterInstagram

Company info
Website
Phone
(857) 285-6200
Location
40 Erie Street
Cambridge
Massachusetts
02139
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert